Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast CancerJuan P. Cerliani, Claudia Lanari|Cancer Research|2011Cited by 87
Progestin and antiprogestin responsiveness in breast cancer is driven by the <scp>PRA</scp>/<scp>PRB</scp> ratio <i>via</i><scp>AIB</scp>1 or <scp>SMRT</scp> recruitment to the <scp><i>CCND</i></scp><i>1</i> and <scp><i>MYC</i></scp> promotersVictoria Wargon, Claudia Lanari|International Journal of Cancer|2014Cited by 39
Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancerCaroline A. Lamb, Claudia Lanari|Endocrine Related Cancer|2018Cited by 31
Referee report. For: Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells [version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]Claudia Lanari, Andrés Elía|Faculty of 1000 Research Ltd|2024Cited by 0